Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123619432 | 12361943 | 2 | F | 2009 | 20160808 | 20160512 | 20160815 | EXP | US-DSJP-DSU-2016-115450 | DAIICHI | 0.00 | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123619432 | 12361943 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, UNK | U | 21286 | 40 | MG | TABLET | |||||||
| 123619432 | 12361943 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/25 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 123619432 | 12361943 | 3 | SS | TRIBENZOR | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | UNK | U | 0 | FILM-COATED TABLET | |||||||||
| 123619432 | 12361943 | 4 | SS | INVOKANA | CANAGLIFLOZIN | 1 | UNK | 0 | |||||||||||
| 123619432 | 12361943 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, QD | 0 | 300 | MG | TABLET | QD | ||||||
| 123619432 | 12361943 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 123619432 | 12361943 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 12.5 MG, BID | 0 | 12.5 | MG | TABLET | BID | ||||||
| 123619432 | 12361943 | 8 | C | CEPHALEXIN /00145501/ | CEPHALEXIN | 1 | Oral | 500 MG, BID | 0 | 500 | MG | TABLET | BID | ||||||
| 123619432 | 12361943 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 123619432 | 12361943 | 10 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, QD | 0 | 60 | MG | SLOW RELEASE CAPSULES | QD | ||||||
| 123619432 | 12361943 | 11 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 5 MG, QID, AS NEEDED | 0 | 5 | MG | TABLET | QID | ||||||
| 123619432 | 12361943 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 123619432 | 12361943 | 13 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Oral | 2 MG, ONCE EVERY 4HR, AS NEEDED | 0 | 2 | MG | TABLET | Q4H | ||||||
| 123619432 | 12361943 | 14 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 0.06 IU/L, QD | 0 | SOLUTION FOR INJECTION/INFUSION | QD | ||||||||
| 123619432 | 12361943 | 15 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 10 MG-325 MG, ONCE EVERY 6HR, AS NEEDED | 0 | 1 | DF | TABLET | Q6H | ||||||
| 123619432 | 12361943 | 16 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | UNK, AS NEEDED | 0 | SOLUTION FOR INJECTION/INFUSION | |||||||||
| 123619432 | 12361943 | 17 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, ONCE EVERY 6HR, AS NEEDED | 0 | 25 | MG | TABLET | Q6H | ||||||
| 123619432 | 12361943 | 18 | C | VASCEPA | ICOSAPENT ETHYL | 1 | Oral | 2 G, BID | 0 | 2 | G | CAPSULE | BID | ||||||
| 123619432 | 12361943 | 19 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Sublingual | 1000 ?G, QD | 0 | 1000 | UG | SUBLINGUAL TABLET | QD | ||||||
| 123619432 | 12361943 | 20 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123619432 | 12361943 | 1 | Hypertension |
| 123619432 | 12361943 | 2 | Hypertension |
| 123619432 | 12361943 | 3 | Hypertension |
| 123619432 | 12361943 | 4 | Product used for unknown indication |
| 123619432 | 12361943 | 5 | Product used for unknown indication |
| 123619432 | 12361943 | 6 | Product used for unknown indication |
| 123619432 | 12361943 | 7 | Product used for unknown indication |
| 123619432 | 12361943 | 8 | Product used for unknown indication |
| 123619432 | 12361943 | 9 | Product used for unknown indication |
| 123619432 | 12361943 | 10 | Product used for unknown indication |
| 123619432 | 12361943 | 11 | Product used for unknown indication |
| 123619432 | 12361943 | 12 | Product used for unknown indication |
| 123619432 | 12361943 | 13 | Product used for unknown indication |
| 123619432 | 12361943 | 14 | Product used for unknown indication |
| 123619432 | 12361943 | 15 | Product used for unknown indication |
| 123619432 | 12361943 | 16 | Product used for unknown indication |
| 123619432 | 12361943 | 17 | Product used for unknown indication |
| 123619432 | 12361943 | 18 | Product used for unknown indication |
| 123619432 | 12361943 | 19 | Product used for unknown indication |
| 123619432 | 12361943 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123619432 | 12361943 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123619432 | 12361943 | Acute kidney injury | |
| 123619432 | 12361943 | Crohn's disease | |
| 123619432 | 12361943 | Gastritis | |
| 123619432 | 12361943 | Haematochezia | |
| 123619432 | 12361943 | Immunodeficiency | |
| 123619432 | 12361943 | Pancreatitis acute |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123619432 | 12361943 | 1 | 200904 | 0 | ||
| 123619432 | 12361943 | 2 | 200904 | 0 | ||
| 123619432 | 12361943 | 3 | 200904 | 0 | ||
| 123619432 | 12361943 | 4 | 2014 | 0 |